The clinical performance is complex and often involves multi-systematic stress. Early identification and standardized diagnosis are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in linking teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine disorders have been significantly improved. Treatment requires close monitoring of therapeutic effects and adverse reactions, adapting to timely regimens based on changes in the condition.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of pervasive pulmonary haemorrhagic DAH. The platform serves the China International Medical Service System, a team of domestic and international experts with authority in the field of infectious respiratory digestive endocrine disorders, to provide the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.